Financial Reports
Related Searches:
Filter by:
241 - 255 of 674 results
January 27, 2011
Byetta sales slip, but losses narrow while company waits on Bydureon
Read More »
January 27, 2011
Plavix sales continue to roll, while Sprycell, Baraclude and Orencia grow
Read More »
January 26, 2011
Product revenues rise, offset by drop in Tamiflu royalties
Read More »
January 25, 2011
Worldwide Pharmaceutical sales were $22.4 billion for the year (-1%).
Read More »
January 25, 2011
U.S. product sales were flat at $2.9 billion in the quarter and included a $65 million unfavorable impact due to U.S. health care reform.
Read More »
December 17, 2010
Commercial manufacturing revenues were flat at $144.8 million in the quarter.
Read More »
November 10, 2010
Growth in the quarter was attributed to growth in Lab Services and Manufacturing Services.
Read More »
November 9, 2010
Total contract revenue for the quarter was $42.9 million (+8%).
Read More »
November 9, 2010
Early Stage revenues were $6.3 million (-4%). Late Stage revenues were $76.2 million (-17%).
Read More »
November 4, 2010
RMS segment sales were $159.3 million in the quarter (-3%) and PCS segment sales were down 13% to $116.8 million.
Read More »
241 - 255 of 674 results
